Professional Summary
Professional Overview
Terry Kohler is an experienced finance executive with a strong background in the pharmaceutical industry. As the Chief Financial Officer at Optinose, he is responsible for leading the company's financial strategy, overseeing all financial operations, and driving the organization's growth and profitability.
Experience Summary
Current Role
As the Chief Financial Officer at Optinose since October 2024, Terry is instrumental in shaping the company's financial direction and ensuring the successful execution of its business objectives. In this role, he oversees all aspects of financial planning, analysis, reporting, and risk management, while also playing a key role in strategic decision-making and capital allocation.
Career Progression
Prior to joining Optinose, Terry served as the Chief Financial Officer at Verrica Pharmaceuticals from 2021 to 2024, where he played a pivotal role in the company's financial and operational transformation. Before that, he held various finance leadership positions at Endo, including Vice President of Corporate Development and Treasurer, as well as Vice President of Finance for the Branded Pharmaceuticals division. Earlier in his career, Terry gained valuable experience as a Director at SSG Capital Advisors and participated in the MBA Leadership Development Program at Johnson & Johnson.
Academic Background
Terry holds a Master of Business Administration (MBA) degree, which has provided him with a strong foundation in financial management, strategic planning, and corporate governance.
Areas of Expertise
Terry's areas of expertise include financial strategy, treasury management, mergers and acquisitions, financial modeling, and performance optimization. He has a deep understanding of the pharmaceutical industry, with a track record of driving operational efficiencies, improving profitability, and supporting the successful commercialization of pharmaceutical products.
Professional Impact
Throughout his career, Terry has demonstrated a strong commitment to driving financial excellence and supporting the growth and expansion of the organizations he has served. He has played a key role in securing strategic partnerships, optimizing financial processes, and enhancing shareholder value. Terry's leadership and collaborative approach have earned him a reputation as a trusted advisor and strategic partner within the industry.
Conclusion
With his extensive experience in the pharmaceutical industry and his proven ability to navigate complex financial and operational challenges, Terry Kohler is well-positioned to continue driving Optinose's success as its Chief Financial Officer. His strategic vision, financial acumen, and commitment to excellence make him a valuable asset to the organization.